Comments

Entourage Health

Q: What sector and industry does Entourage Health (ETRGF) operate in?

Entourage Health is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.

ETRGFOTCPK

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.00468

0.000184.00%

At close: -

Entourage Health (ETRGF) Forecast

News Earnings Entourage Health (ETRGF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Entourage Health (OTC:ETRGF) Stock Quotes, Forecast and News Summary

Entourage Health Stock (OTC: ETRGF) stock price, news, charts, stock research, profile.

Open	$0.00
Close	$0.00
Volume / Avg.	1.37K / 37.99K
Day Range	$0.00 - $0.00
52 Wk Range	0.00 - 0.01
Market Cap	$1.44M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

Canadian Cannabis Co. Entourage Health Shares Spike On 8% YoY Q3 Revenue Growth, Reduced Losses

Canadian cannabis producer Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) announced on Friday its third quarter financial results for the three months ended Sept. 30, 2024. The company reported an 8% year-over-year increase to CA$9.5 million ($6.8 million) in net revenue for the period. Sequentially, net revenue increased by 2.1%. George Scorsis, the company's CEO and chair, said the revenue growth is a result of a strategic shift into different markets. The move allowed the company to "diversify and tap into new opportunities," Scorsis said.

Jelena Martinovic

Entourage Cannabis Co.'s Q2 Revenue Drops Nearly 9% YoY, CEO 'Optimistic' About Future Opportunities

Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) announced on Tuesday its second quarter financial results for the three-month period ending June 30, 2024. The Toronto-based company reported a total revenue of CA$12.2 million ($9 million), including net revenue of $9.3 million, before excise duties and discounts, representing a decrease from CA$13.4 million in the prior year's period. The company touted "strong impact" with new product launches in Alberta, Ontario, and British Columbia.

Jelena Martinovic

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30, 2024, on Wednesday, Aug. 14, 2024. cbdMD, Inc. (NYSE: YCBD) said it will host a conference call at 4:20 pm Eastern Time, on Wednesday, Aug. 14, 2024, to discuss the company's June 30, 2024 third quarter of fiscal 2024 financial results and business progress. Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) its second quarter 2024 financial results will be released after market close on Monday, Aug. 26, 2024. The company will host a conference call to discuss the results and provide an operational update and recap of achievements on Tuesday, Aug. 27, 2024. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, Aug. 13, 2024, before market open. The company will host a conference call to discuss its results with details the same day at 8:00 am Eastern Time.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.00
Close	$0.00
Volume / Avg.	1.37K / 37.99K
Day Range	$0.00 - $0.00
52 Wk Range	0.00 - 0.01
Market Cap	$1.44M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Entourage Health (ETRGF) stock?

You can purchase shares of Entourage Health (OTCPK:ETRGF) through any online brokerage.

View our list of the best stock brokerages

Who are Entourage Health (ETRGF) competitors?

There are no as such competitors for Entourage Health.

What is the forecast, or price target, for Entourage Health (ETRGF) stock?

There is no analysis for Entourage Health to provide a consensus price target.

What is the current price for Entourage Health (ETRGF)?

The stock price for Entourage Health (OTCPK: ETRGF) is $0.00468 last updated January 21, 2025 at 2:13 PM EST.

Does Entourage Health (ETRGF) pay a dividend?

There are no upcoming dividends for Entourage Health.

When is Entourage Health (OTCPK:ETRGF) reporting earnings?

Entourage Health does not have any upcoming earnings scheduled.

Is Entourage Health (ETRGF) going to split?

There is no upcoming split for Entourage Health.

What sector and industry does Entourage Health (ETRGF) operate in?

Entourage Health is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCPK.

Comments

Entourage Health

Entourage Health (ETRGF) Forecast

Entourage Health (OTC:ETRGF) Stock Quotes, Forecast and News Summary

Recent News

Financials

Compare

FAQ

How do I buy Entourage Health (ETRGF) stock?

Who are Entourage Health (ETRGF) competitors?

What is the forecast, or price target, for Entourage Health (ETRGF) stock?

What is the current price for Entourage Health (ETRGF)?

Does Entourage Health (ETRGF) pay a dividend?

When is Entourage Health (OTCPK:ETRGF) reporting earnings?

Is Entourage Health (ETRGF) going to split?

What sector and industry does Entourage Health (ETRGF) operate in?

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga